Although novel drugs such as BTK inhibitors, JAK inhibitors and ROCK2 inhibitors expand treatment options, irreversible fibrotic progression and severe immune dysfunction along with serious infectious complications remain challenging. The gene discussed is BTK; the disease is immune system disorder.